Bookmark

Add to MyYahoo RSS

Shire plc News

News on Shire plc (Ticker: SHPGY) continually updated from thousands of sources around the net.

Monday | Seeking Alpha

Tracking John Paulson's Paulson & Company Portfolio - Q2 2014 Update

Paulson & Co. added Covidien plc and increased Cobalt International Energy & Shire plc stakes this quarter.

Comment?

Related Topix: Manufacturing, Industrial Machines, Startups, Foley, Covidien, Starting Point, VNUS Medical Technologies, Healthcare Industry, Biotech

INCROYABLE - Relais France 4x400m Femme - Championnats d'Europe 2014 - INCREDIBLE F...

Watch A Tortoise Chase Down A Remote-Controlled Truck With ALL ITS MIGHT

Critics Slam 'Ice Bucket Challenge' as 'Slacktivism' and 'Stunt Philanthropy'

Police Fatally Shoot Another Black Male Near Ferguson

Fri Aug 15, 2014

Seeking Alpha

Supernus Finding Success, Looks Undervalued

Background : A spin-off from Shire plc , Supernus Pharmaceuticals, Inc. is a niche pharmaceutical company.

Comment?

Related Topix: Biotech, Medicine, Neurology, Epilepsy, Health

Wed Aug 13, 2014

Hispanic Business

Intellect Neurosciences, Inc. Issues Letter to Shareholders

Dear Intellect Stakeholder, I would like to update you regarding the clinical development status of OX1, the antioxidant molecule that is the subject of an exclusive license agreement between merged with Shire Plc.

Comment?

Related Topix: Alzheimer's, Biotech

Mon Aug 11, 2014

Seeking Alpha

Inversion Deals Are Costing The U.S.

The life sciences industry, particularly pharmaceuticals, is ripe with competition.

Comment?

Related Topix: Biotech, Movetis, Salix Pharmaceuticals, Medicine, Healthcare Industry, Salix, PA, Medtronic, Medical Equipment

Thu Aug 07, 2014

AmericanBankingNews.com

Shire PLC Given Average Recommendation of "Buy" by Brokerages

Shire PLC has been given an average recommendation of "Buy" by the twelve ratings firms that are covering the stock, AnalystRatings.NET reports .

Comment?

Related Topix: Biotech

Business Wire

INVESCO Limited UK Regulatory Announcement: Form 8.3 - Shire plc

If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer? Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure ... (more)

Comment?

Related Topix: Biotech

Wed Aug 06, 2014

The Washington Post

Shire, AstraZeneca Fall After Treasury Looks to Deter Inversions

Drugmakers Shire Plc and AstraZeneca Plc fell in New York trading after the Obama administration said it would seek to deter U.S. companies from buying foreign competitors to dodge domestic taxes.

Comment?

Related Topix: Biotech, Pfizer, Medicine, Healthcare Industry, US Politics, Barack Obama, Business News

Tue Aug 05, 2014

Seeking Alpha

Is AbbVie A Long-Term Buy?

The acquisition of Shire would not only provide a tax advantage to AbbVie but would also help the company to grow its revenue base through portfolio expansion.

Comment?

Related Topix: Biotech

Mon Aug 04, 2014

BioSpace

ANI Pharmaceuticals, Inc. Acquires Vancocin?? Capsules And Additional Vancomycin Assets From

In addition, ANI acquired from Shire approved ANDAs for the currently non-marketed products vancomycin hydrochloride injectable 500 mg, 1 gm and 10 gm is an integrated specialty pharmaceutical company developing, manufacturing, and marketing branded and generic prescription pharmaceuticals.

Comment?

Related Topix: Vancocin, Vancomycin Hydrochloride (generic), Medicine, Biotech, Marketing, Drugs

Fri Aug 01, 2014

Sys-Con Media

ANI Pharmaceuticals Acquires VancocinA Capsules and Additional Vancomycin Assets from Shire

In addition, ANI acquired from Shire approved ANDAs for the currently non-marketed products vancomycin hydrochloride injectable 500 mg, 1 gm and 10 gm is an integrated specialty pharmaceutical company developing, manufacturing, and marketing branded and generic prescription pharmaceuticals.

Comment?

Related Topix: Biotech, Marketing, Drugs

Seeking Alpha

AbbVie Shareholders Prevail

ABBV announced a $54 billion acquisition of Shire PLC, and a new tax domicile in the UK, lowering its corporate tax rate by 9%.

Comment?

Related Topix: Biotech

Business Wire

Barclays PLC Uk Regulatory Announcement: Form 8.3 - Shire PLC

Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer? Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing Details of any open derivative or option positions, or agreements to purchase or ... (more)

Comment?

Related Topix: Biotech

Tue Jul 29, 2014

BioSpace

Aurinia Adds Financial Expertise To Its Board Of Directors

Aurinia Pharmaceuticals Inc. today announced that Mr. Charles Rowland Jr. has joined its Board of Directors and will assume the role of Audit Committee Chair.

Comment?

Related Topix: Biotech, ViroPharma, Medicine, Healthcare Industry, Endo Pharmaceuticals Holdings

BioSpace

Shire Announces Award Recipients For 2014 Michael Yasick ADHD Scholarship

Shire plc announces the recipients of its 2014 Michael Yasick ADHD Scholarship. The program is for individuals in the United States diagnosed with Attention-Deficit/Hyperactivity Disorder who are pursuing higher education at a college, vocational school, or technical school.

Comment?

Related Topix: Medicine, ADHD, Health, Biotech, Family, Adolescents and Pre-Teens, Pennsylvania

The Spokesman-Review

Robert J. Samuelson: Solving corporate tax flight - Tue, 29 Jul 2014 PST

Corporate America's latest public relations disaster comes under the banner "tax inversion."

Comment?

Related Topix: Biotech, Social Security, Personal Finance, Healthcare Law, Law

Mon Jul 28, 2014

CFO

Another Tax Inversion Deal in the Works

The hue and cry over tax inversions is not stopping companies from proceeding with more mergers that take advantage of the tactic.

Comment?

Related Topix: Biotech

Fri Jul 25, 2014

The Washington Post

AbbVie Quarterly Profit Beats Analyst Estimates on Humira Sales

AbbVie Inc., the drugmaker that's buying Shire Plc and lowering its tax rate by moving its legal address overseas, said second-quarter profit rose 2.8 percent on strong sales of arthritis drug Humira.

Comment?

Related Topix: Biotech, Medicine, Arthritis, Health, North Chicago, IL, Business News

Wed Jul 23, 2014

Medical News

Shire, ArmaGen partner to develop AGT-182 drug for treatment of Hunter syndrome

Shire plc , the global specialty biopharmaceutical company, and ArmaGen, a US privately held biotechnology company, today announced a worldwide licensing and collaboration agreement for AGT-182, an investigational enzyme replacement therapy for the potential treatment of both the central nervous system and somatic manifestations in patients with ... (more)

Comment?

Related Topix: Biotech, Medicine, Health

Boston.com

JEFF JACOBYInverters aren't deserters

THE CORPORATE inversions just keep on coming, and the White House and its allies are calling them unpatriotic.

Comment?

Related Topix: US News, Prison, Biotech, US Politics, US Senate, Carl Levin, Democrat, Opinion

Mon Jul 21, 2014

AmericanBankingNews.com

Shire PLC Lowered to Neutral at Buckingham Research

Several other analysts have also recently commented on the stock. Analysts at SunTrust downgraded shares of Shire PLC from a "buy" rating to a "neutral" rating in a research note on Monday.

Comment?

Related Topix: Biotech

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••